News
PESG issues a new briefing following PolyPid’s clinical success; Revolutionary 58% Reduction in Surgical Site Infections Positions PolyPid’s D-PLEX100 as Potential New Standard of Care in the ...
The SHIELD II trial delivered unequivocal evidence of D-PLEX100's clinical utility across multiple measures of surgical outcomes. In the 798-patient cohort with large abdominal incisions, D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback